Synthesis and comparative carbonic anhydrase inhibition of new Schiff's bases incorporating benzenesulfonamide, methanesulfonamide, and methylsulfonylbenzene scaffolds.
Acetazolamide
Benzenesulfonamide
Carbonic anhydrase inhibition
Molecular docking
Schiff’s base
Synthesis
Journal
Bioorganic chemistry
ISSN: 1090-2120
Titre abrégé: Bioorg Chem
Pays: United States
ID NLM: 1303703
Informations de publication
Date de publication:
11 2019
11 2019
Historique:
received:
26
05
2019
revised:
25
08
2019
accepted:
27
08
2019
pubmed:
8
9
2019
medline:
23
10
2020
entrez:
8
9
2019
Statut:
ppublish
Résumé
Herein, we report the synthesis, characterization, and carbonic anhydrase (CA) inhibition of the newly synthesized Schiff's bases 4-18 with benzenesulfonamide, methanesulfonamide, and methylsulfonylbenzene scaffolds. The compound inhibition profiles against human CA (hCA) isoforms I, II, IX, and XII were compared to those of the standard inhibitors, acetazolamide (AAZ) and SLC-0111 (a CA inhibitor in Phase II clinical trials for the treatment of hypoxic tumors). The hCA I was inhibited by compounds 4a-8a with inhibition constants (K
Identifiants
pubmed: 31493707
pii: S0045-2068(19)30857-0
doi: 10.1016/j.bioorg.2019.103225
pii:
doi:
Substances chimiques
Carbonic Anhydrase Inhibitors
0
Schiff Bases
0
Sulfonamides
0
methanesulfonamide
3144-09-0
Carbonic Anhydrases
EC 4.2.1.1
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
103225Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.